Rocket Pharmaceuticals Files 8-K on Financials
Ticker: RCKTW · Form: 8-K · Filed: May 8, 2025 · CIK: 1281895
| Field | Detail |
|---|---|
| Company | Rocket Pharmaceuticals, Inc. (RCKTW) |
| Form Type | 8-K |
| Filed Date | May 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, operations, exhibits
TL;DR
Rocket Pharma dropped its 8-K, check the financials.
AI Summary
Rocket Pharmaceuticals, Inc. filed an 8-K on May 8, 2025, reporting on its Results of Operations and Financial Condition, as well as Financial Statements and Exhibits. The filing details the company's financial status and includes exhibits related to its operations. The company, formerly known as Inotek Pharmaceuticals Corp., is incorporated in Delaware and headquartered in New York.
Why It Matters
This 8-K filing provides investors with crucial updates on Rocket Pharmaceuticals' financial health and operational performance, enabling informed investment decisions.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not indicate any immediate or significant risks.
Key Players & Entities
- Rocket Pharmaceuticals, Inc. (company) — Registrant
- Inotek Pharmaceuticals Corp. (company) — Former company name
- May 8, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- New York (location) — Principal executive offices city
- Cranbury, NJ (location) — Principal executive offices
FAQ
What specific financial information is being reported in this 8-K?
This 8-K reports on the 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was this 8-K filing submitted?
The filing was submitted on May 8, 2025.
What is the primary business of Rocket Pharmaceuticals, Inc. according to the filing?
The filing lists the Standard Industrial Classification as 'PHARMACEUTICAL PREPARATIONS [2834]'.
Has Rocket Pharmaceuticals, Inc. operated under any other names?
Yes, the company was formerly known as Inotek Pharmaceuticals Corp., with a name change date of February 26, 2004.
Where are Rocket Pharmaceuticals, Inc.'s principal executive offices located?
The principal executive offices are located at 9 Cedarbrook Drive, Cranbury, NJ 08512.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 8, 2025 regarding ROCKET PHARMACEUTICALS, INC. (RCKTW).